Eli Lilly (LLY) is discontinuing some of its insulin presentations across selected countries

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

Israeli senior official says we are not worried about the talks between Washington and Tehran, Al Hadath reports

Indian Foreign Minister says detailed telecommunications were had with US Secretary of State Rubio; discussions focused on the Middle East conflict and its impact on the international economy; also spoke about energy security concerns

Eli Lilly (LLY) is discontinuing some of its insulin presentations across selected countries

BoC announces Deputy Governor Mendes to leave governing council on April 10th and Deputy Governor Kozicki will retire on July 15th

US President Trump tells Republicans not to deal with Democrats until voting law is passed; no deal without voter ID law; is tying voter ID and DHS funding together

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

All discontinuations expected to occur before Q2 2027, after which affected insulin presentations will no longer be available

Context

Eli Lilly's decision to discontinue certain insulin presentations indicates a strategic pivot in its product offerings, likely reflective of evolving market conditions or regulatory pressures. This move could signal potential operational efficiencies or shifts in focus towards more profitable segments, potentially impacting their competitive positioning in the pharmaceuticals market.

Related headlines

The feed had this first.

Use the Platform